CAST PHARMA Announces a New Office in Denmark

CAST PHARMACAST PHARMA, a premier European 3D pharmaceutical and biomedical animation production company, has announced the opening of the new office in Ballerup, Denmark. This new office will allow Cast Pharma to meet the growing demand in the Northern Europe pharmaceutical market and to improve services to existing clients.

"With the increase in technology capabilities and the rapidly growing demand on patient education as well as the health care professionals' continuous training needs, more and more pharmaceutical companies are moving to 3D visualization techniques to get their message across to their target audience and differentiate themselves from their competitors," commented CAST PHARMA owner, Mr. Stefan Wolf. "Our new office is represented by Mrs. Antje Madsen, a skilled, top line professional that will better serve our European clients and will allow us to meet the increasing demands of 3D mode of action animation production."

With the extended capabilities of its new office, CAST PHARMA will focus on promoting its advanced services and increasing its client base in the Northern Europe region. Over the last few years, CAST PHARMA has positioned itself as an unique, advanced and highly professional company on the German pharmaceutical market. As result, this growing is a perfect fit for CAST PHARMA to expand its services and to position itself as the leading and the premier European 3D pharmaceutical and biomedical animation production company.

For further information, please visit:
http://www.cast-pharma.com

About CAST PHARMA
CAST PHARMA ia a premier European 3D pharmaceutical and biomedical animation production company. For more information, please visit www.cast-pharma.com.

Source: PharmaNews.eu

Most Popular Now

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...

GSK announces positive Phase IIa study results for…

GSK plc (LSE/NYSE: GSK) announced positive results from a Phase IIa study demonstrating that GSK3036656, a first-in-class investigational antitubercular agent, was well t...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Unusual type of antibody shows ultrapotent activit…

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identifie...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Machine learning can help predict patient response…

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...